We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors (LDTam)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01196936
First Posted: September 9, 2010
Last Update Posted: December 8, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University Health Network, Toronto
University of Michigan
Dana-Farber Cancer Institute
Mayo Clinic
University of Washington
City of Hope National Medical Center
M.D. Anderson Cancer Center
University of Chicago
University of Minnesota - Clinical and Translational Science Institute
University of Colorado, Denver
Wake Forest University
Information provided by (Responsible Party):
Smitia Bhatia, University of Alabama at Birmingham
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2019
  Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)